Vanda Pharmaceuticals Inc. News - VNDA

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
CHART Trader
Monthly Subscription
for only
$30.66
SMALL CAP PRO
Monthly Subscription
for only
$49.05
VAT not included
Company Name Stock Ticker Symbol Market Type ISIN Company Description
Vanda Pharmaceuticals Inc. VNDA NASDAQ Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  +0 +0% 21.11 - - - 21.11 08:09:21
more quote information »
Industry Sector
Biotechnology

Recent News

Date Time Source Heading
2/19/201907:05EDGARAnnual Report (10-k)
2/14/201917:55EDGARAmended Statement of Ownership (sc 13g/a)
2/14/201915:01EDGARAmended Statement of Ownership (sc 13g/a)
2/14/201914:53EDGARAmended Statement of Ownership (sc 13g/a)
2/14/201907:53EDGARStatement of Ownership (sc 13g)
2/13/201916:12EDGARCurrent Report Filing (8-k)
2/13/201916:01PRNUSVanda Pharmaceuticals Reports Fourth Quarter 2018 and Full..
2/13/201915:16BWINVESTIGATION REMINDER: The Schall Law Firm Announces it is..
2/12/201916:22BWINVESTIGATION ALERT: The Schall Law Firm Announces it is..
2/11/201919:00BWINVESTOR ALERT: Kirby McInerney LLP Announces an..
2/11/201910:32EDGARAmended Statement of Ownership (sc 13g/a)
2/06/201906:09EDGARCurrent Report Filing (8-k)
2/05/201917:05PRNUSVanda Pharmaceuticals Takes a Stand Against Unnecessary..
1/31/201914:47EDGARAmended Statement of Ownership (sc 13g/a)
1/25/201909:30PRNUSVanda Pharmaceuticals to Announce Fourth Quarter and Full..
1/04/201916:40EDGARStatement of Changes in Beneficial Ownership (4)
1/04/201916:36EDGARStatement of Changes in Beneficial Ownership (4)
1/04/201916:35EDGARStatement of Changes in Beneficial Ownership (4)
1/04/201916:34EDGARStatement of Changes in Beneficial Ownership (4)
12/20/201807:00PRNUSFDA Accepts HETLIOZ® (tasimelteon) Supplemental New Drug..
12/10/201816:34EDGARCurrent Report Filing (8-k)
12/10/201807:00PRNUSVanda Announces Positive Pivotal Study Results for HETLIOZ®..
12/03/201816:33EDGARCurrent Report Filing (8-k)
12/03/201806:00PRNUSVanda Announces Positive Phase II Study Results for..
11/08/201817:35PRNUSVanda Pharmaceuticals Announces Participation at November..
11/07/201817:11EDGARQuarterly Report (10-q)
11/07/201816:08EDGARCurrent Report Filing (8-k)
11/07/201816:01PRNUSVanda Pharmaceuticals Reports Third Quarter 2018 Financial..
11/01/201809:40PRNUSVanda Receives FDA Letter Regarding Corporate Webpage
10/22/201816:30PRNUSVanda Pharmaceuticals to Announce Third Quarter 2018..
10/10/201816:29EDGARAmended Statement of Ownership (sc 13g/a)
10/04/201816:33EDGARCurrent Report Filing (8-k)
9/26/201816:30PRNUSVanda Pharmaceuticals Announces Participation at Oppenheimer..
9/25/201818:26PRNUSRollins Set to Join S&P 500; Inogen to Join S&P MidCap 400;..
9/20/201817:05PRNUSVanda Announces Listing of a New HETLIOZ® Patent in the FDA..
9/12/201819:00PRNUSHETLIOZ® (Tasimelteon) Driving Study Demonstrates No..
9/04/201816:35PRNUSVanda Pharmaceuticals Announces Participation at September..
8/14/201817:27EDGARCurrent Report Filing (8-k)
8/14/201817:09EDGARStatement of Changes in Beneficial Ownership (4)
8/14/201817:03EDGARInitial Statement of Beneficial Ownership (3)
8/14/201816:45PRNUSVanda Wins Denial of Petition For Rehearing on Fanapt®
8/13/201816:01PRNUSVanda Pharmaceuticals Announces the Appointment of General..
8/02/201807:03EDGARQuarterly Report (10-q)
8/01/201816:23EDGARCurrent Report Filing (8-k)
8/01/201816:01PRNUSVanda Pharmaceuticals Reports Second Quarter 2018 Financial..
7/17/201816:30PRNUSVanda Pharmaceuticals to Announce Second Quarter 2018..
6/15/201816:36EDGARStatement of Changes in Beneficial Ownership (4)
6/15/201816:36EDGARStatement of Changes in Beneficial Ownership (4)
6/15/201816:34EDGARStatement of Changes in Beneficial Ownership (4)
6/15/201816:33EDGARStatement of Changes in Beneficial Ownership (4)
See more news about this stock »


Your Recent History
NASDAQ
VNDA
Vanda Phar..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.